tiprankstipranks
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
Australian Market

Australian Clinical Labs Ltd (ACL) Financial Statements

Compare
46 Followers

Australian Clinical Labs Ltd Financial Overview

Australian Clinical Labs Ltd's market cap is currently AU$744.14M. The company's EPS TTM is AU$0.12; its P/E ratio is 30.84; and it has a dividend yield of 3.23%. Australian Clinical Labs Ltd is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is AU$0.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 689.73MAU$ 692.10MAU$ 989.30MAU$ 641.31MAU$ 487.53M
Gross ProfitAU$ 247.36MAU$ 566.02MAU$ 781.71MAU$ 521.73MAU$ 85.04M
Operating IncomeAU$ 56.91MAU$ 51.85MAU$ 256.24MAU$ 97.59MAU$ 15.53M
EBITDAAU$ 169.65MAU$ 184.93MAU$ 372.75MAU$ 196.67MAU$ 116.30M
Net IncomeAU$ 23.93MAU$ 35.90MAU$ 178.24MAU$ 60.37MAU$ 41.26M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 26.84MAU$ 19.95MAU$ 26.37MAU$ 35.23MAU$ 35.28M
Total AssetsAU$ 593.06MAU$ 578.91MAU$ 628.04MAU$ 474.70MAU$ 366.05M
Total DebtAU$ 308.90MAU$ 316.32MAU$ 262.38MAU$ 294.26MAU$ 221.21M
Net DebtAU$ 282.76MAU$ 296.36MAU$ 236.00MAU$ 259.03MAU$ 186.36M
Total LiabilitiesAU$ 415.30MAU$ 406.24MAU$ 395.49MAU$ 392.79MAU$ 297.06M
Stockholders' EquityAU$ 177.53MAU$ 172.42MAU$ 232.44MAU$ 81.90MAU$ 68.99M
Cash Flow
Free Cash FlowAU$ 153.09MAU$ 136.75MAU$ 262.83MAU$ 144.36MAU$ 92.36M
Operating Cash FlowAU$ 159.59MAU$ 143.68MAU$ 284.09MAU$ 153.86MAU$ 101.74M
Investing Cash FlowAU$ -7.25MAU$ -12.18MAU$ -72.04MAU$ -6.08MAU$ -9.96M
Financing Cash FlowAU$ -146.14MAU$ -137.88MAU$ -220.91MAU$ -147.37MAU$ -60.92M
Currency in AUD

Australian Clinical Labs Ltd Earnings and Revenue History

Australian Clinical Labs Ltd Debt to Assets

Australian Clinical Labs Ltd Cash Flow

Australian Clinical Labs Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis